Developed and maintained by InvoIntell
NaviHTA TM
Comprehensive HTA Intelligence and Strategic Decision-Making
Comprehensive HTA Intelligence and Strategic Decision-Making
.
A comprehensive database providing detailed insights from Health Technology Assessment (HTA) reports across major European agencies. This powerful tool enables data-driven market access strategies and competitive positioning through rigorous analysis of historical HTA decisions.
Machine learning-based models that predict HTA appraisal outcomes using information typically available in a Target Product Profile. The models estimate the probability of receiving a recommendation aligned with your target and quantify the impact of various factors influencing this probability.
Coverage
Agencies: HAS, NICE, SMC, GBA-IQWIG
Time period: Since January 2018 (3-month processing delay)
Therapeutic scope: All therapeutic areas included
Quality-Assured Data Extraction Proces
* As of April 2025
The NaviHTA models have high predictive performance.
Probability of actual ASMR category according predicted ASMR category
Example: If the predicted ASMR category if V, there is a 94% chance that the product actually receives an ASMR V.
Each probability estimate is accompanied by an analysis of influential factors, as illustrated by the example below.
Top 10 factors influencing the probability of ASMR I to IV for a product
This figure is for illustrative purpose only. The influence of different factors vary according to the context.